This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by DAVE, K. S. Articles by IONESCU, M. I. Search for Related Content PubMed PubMed Citation Articles by DAVE, K. S. Articles by IONESCU, M. I.

(Circulation. 1972;46:240.)
© 1972 American Heart Association, Inc.

---

Chronic Hemolysis following Fascia Lata and Starr-Edwards Aortic Valve Replacement

KAMAL S. DAVE M.S., M.CH.¹; CHAND K. MADAN M.B.B.S.¹; BROJESH C. PAKRASHI M.R.C.P.¹; BRYON E. ROBERTS M.D.¹; MARIAN I. IONESCU M.D.¹

¹ From The General Infirmary at Leeds and Leeds University, Leeds, England.

Sixty-two patients were investigated for chronic intravascular hemolysis from 3 months to 6 years following aortic valve replacement; 27 patients had Starr-Edwards prostheses and 35 fascia lata grafts.

The findings are suggestive of a significantly higher incidence and degree of hemolysis in patients with Starr-Edwards prostheses compared to those with fascia lata grafts. In both groups regurgitation was an important factor in producing hemolysis. In the absence of regurgitation fascia lata grafts do not produce significant hemolysis, while Starr-Edwards valves traumatize the red cells even in the absence of regurgitation. Starr-Edwards valves of small size are associated with hemolysis more often than larger ones are. Turbulent flow due to the obstructing ball is the probable mechanism of hemolysis in these patients. In most of the patients the degree of hemolysis appears to remain at the same level of activity. In rare instances, however, the hemolysis may regress. The mechanism for this is not clear. In a small number of patients, also, progressive hemolysis may necessitate removal and replacement of the valve.

Key Words: Biologic tissue valves • Lactic dehydrogenase • Hemolytic anemia • Red cell fragmentation • Haptoglobins • Regurgitant valves

Submitted on December 21, 1971
Accepted on February 1, 1972